These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26190176)

  • 1. Anticancer Organometallic Osmium(II)-p-cymene Complexes.
    Păunescu E; Nowak-Sliwinska P; Clavel CM; Scopelliti R; Griffioen AW; Dyson PJ
    ChemMedChem; 2015 Sep; 10(9):1539-47. PubMed ID: 26190176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
    Nowak-Sliwinska P; Clavel CM; Păunescu E; te Winkel MT; Griffioen AW; Dyson PJ
    Mol Pharm; 2015 Aug; 12(8):3089-96. PubMed ID: 26158308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organometallic ruthenium and osmium compounds of pyridin-2- and -4-ones as potential anticancer agents.
    Henke H; Kandioller W; Hanif M; Keppler BK; Hartinger CG
    Chem Biodivers; 2012 Sep; 9(9):1718-27. PubMed ID: 22976964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
    Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
    J Med Chem; 2015 Apr; 58(8):3356-65. PubMed ID: 25812075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
    Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
    Wang Z; Qian H; Yiu SM; Sun J; Zhu G
    J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
    Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
    J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF; Parsons S; Sadler PJ
    J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
    Peacock AF; Sadler PJ
    Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a highly tumor-selective organometallic ruthenium(II)-arene complex.
    Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
    J Med Chem; 2014 Apr; 57(8):3546-58. PubMed ID: 24669938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.
    Păunescu E; Soudani M; Clavel CM; Dyson PJ
    J Inorg Biochem; 2017 Oct; 175():198-207. PubMed ID: 28779652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organometallic osmium arene complexes with potent cancer cell cytotoxicity.
    Fu Y; Habtemariam A; Pizarro AM; van Rijt SH; Healey DJ; Cooper PA; Shnyder SD; Clarkson GJ; Sadler PJ
    J Med Chem; 2010 Nov; 53(22):8192-6. PubMed ID: 20977192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds.
    Păunescu E; McArthur S; Soudani M; Scopelliti R; Dyson PJ
    Inorg Chem; 2016 Feb; 55(4):1788-808. PubMed ID: 26824462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
    Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
    Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells.
    van Rijt SH; Mukherjee A; Pizarro AM; Sadler PJ
    J Med Chem; 2010 Jan; 53(2):840-9. PubMed ID: 20000847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
    Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.
    Barry NP; Pitto-Barry A; Romero-Canelón I; Tran J; Soldevila-Barreda JJ; Hands-Portman I; Smith CJ; Kirby N; Dove AP; O'Reilly RK; Sadler PJ
    Faraday Discuss; 2014; 175():229-40. PubMed ID: 25270092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?
    Hanif M; Henke H; Meier SM; Martic S; Labib M; Kandioller W; Jakupec MA; Arion VB; Kraatz HB; Keppler BK; Hartinger CG
    Inorg Chem; 2010 Sep; 49(17):7953-63. PubMed ID: 20704358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.